precision was evaluated by running the assay on ten consecutive days on one serum poo1. 
Table 1. Precision of the immunoturbidimetric Method
Albumin, g/L
Mean
Within-day(n = 22 each)
11.1

37,39
66.30 Day-to-day(n = 10)
36.85
ods are required. Laser immunonephelometry is more rapid than radial immunodiffusion but requires special apparatus. 
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Letter. The present method was developed to overcome these limitations.
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Materials and Methods
Apparatus
A "high-pressure" liquid chromatograph equipped with a U-SK injector, a guard column, a radial compression module (RCM-100cartridge, reversed-phase), all from Waters Associates, Milford, MA, and a variable-wavelength ultraviolet detector (Schoeffel Monochromator GM 970 and Spectroflow
Monitor SF 770; Kratos, Inc., Westwood, NJ) set at 228 nm were used throughout.
(B) Reagents
Cimetidine and the internal standard (N-cyano-N'-methyl-N"- [3-(4- Precision studies. Intra-assay variability was assessed by six replicate determinations of cimetidine/internal standard peak-height ratios in each of two different plasma samples to which known amounts of cimetidune had been added (3594 and 359.4 ng) . Similarly, we assessed the precision at the low end of the standard curve with the following amounts of cimetidune: 1740, 870, 435, and 69.6 ng. The values chosen represented the extremes of the usual standard curve. In addition, we determined three samples of intermediate concentration (2695.5, 1437.6, and 718.8 ng) in duplicate on the same day.
Jnterasaay performance was determined on seven different days, by the construction of complete standard curves and by the analysis on each day of two plasma samples containing high (6.9 p.g/mL) and low (2.2 g/mL) concentrations of cimetidine.
Recovety studies. The recovery of cimetidune from plasma was determined by comparing the peak-height ratios of pure cimetidine standard with those of plasma samples of known initial and final volumes, to which four different amounts (1740,870, 435, and 69.6 ng) of cimetidine had been added.
Statistical methods.
We used standard methods to calculate the mean, standard deviation, standard error of the mean, coefficient of variation, and linear regression parameters (7). One-way analysis of variance was used to test for differences among the recovery rates of the four different cimetidine concentrations.
Results
Figure LB shows a typical chromatogram obtained from plasma to which both cimetidine and the internal standard had been added. Comparison with the chromatogram in Figure IA demonstrates the enhanced resolution achieved by protonating both cimetidine and the internal standard with dilute acid, which allows the detection of as little as 2.0 ng of cimetidine on-column. At a flow rate of 3 ,mLfmin (pressure of 6900 kPa), the retention times for cimetidune and the internal standard were 2.78 and 2.00 miii, respec-
tively.
Analytical recovery of cimetidine from plasma ranged from 85.9% (SEM 1.4%) to 91.6% (SEM 3.7%), and was independent of concentration over the range 0.28 to 6.98 jzg/mL of plasma.
hntra-assay CVs ranged from 4.04% to 9.41% and were independent of the amount of cimetidine analyzed. Interassay CVs variation ranged from 6.39% to 6.58%, and were also unrelated to the amount of analyte. Day-to-day variation in standard curve parameters were minimal and not statistically significant. standard curve, and for the gastric fluid standard curve, respectively; intercepts were -0.021, 0.1194, and 0.007, respectively.
Discussion
Studies of the pharmacokinetics and pharmacodynamics of cimetidine demand analytical methods that not only are sensitive and specific, but also allow for the efficient throughput of samples. We developed the method described here because the existing methods have low extraction efficiency or do not allow for the rapid determination of small samples with low concentrations of cimetidine. The extraction procedure utilized was modified from that described by Lorenzo and Drayer (5) , and simplified by the elimination of a complex solvent mixture for extraction. We used the back-extraction of protonated cimetidune and internal standard to get the compounds into an organic phase suitable for rapid evaporation. We believe that the enhanced resolution and sensitivity justify the additional steps of protonation and back-extraction.
The high on-column sensitivity of this method should allow the determination of cimetidine in the amounts of plasma that could be obtained from a small laboratory Bloodwas obtainedatthetimesindicatedafterdrug administrationand analyzed es described.Least-squaresestimatesfor distributionvolume(V,)(0.371/kg)and clearance (7 mI/mm per kilogram)are consistentwith resultsof otherstudies( animfil, while the steepness of the lower portion of the standard curve suggests acceptable results for samples with very low concentrations of cimetidine. Figure 2 demonstrates the clinical use of the method. In a study approved by our institutional review board, an apparently healthy woman voluntarily received an intravenous bolus of 400 mg of cimetidine (Tagamet; Smith Kline & French). Blood samples (0.5 mL) were drawn at the times indicated, and analyzed as described. Seven hours after the cimetidine administration, the lowest cimetidune concentration measurable was reached, 0.2 tg/mL. The ability to easily and reproducibly assay cimetidine in both plasma and gastric fluid will facilitate studies of the pharmacokunetic-pharmacodynamic interrelationships of this drug and should aid in the investigation of patients with so-called cimetidine resistance.
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